life science technology park
capital investment
contract services

POLAND ON BIO 2011

poland on bio 2011 washcington

SEARCH

Bio International Convention 2011

Between 27 and 30 June 2011, Jagiellonian Centre of Innovation, together with Partners from all over the country represents Polish biotechnology industry during the BIO International Convention. Welcome to the dedicated website for this event at www.lifescience.pl / bio

 
F1 Pharma announcement
JCI Venture Ltd. has established a new start-up company within it investment port folio. F1 Pharma Ltd. bonds years of experience of talented experts from R&D sector of internationally recognized pharmaceutical company, with capital investment of several hundreds of thousands zloty along with technical support derived from  JCI Venture resources. F1 Pharma focuses on  unique and perspective opportunities of pharmaceutical market, and its operational and business activity conducts at Life Science Technology Park and Bioinqubator, managed by the Jagiellonian Centre of Innovation Ltd.
 
ProManus anouncement
As a ProManus Ltd, the young and talented team of entrepreneurs, possessing patent applications in unique technological solutions, received financial and  technical support from team of JCI Venture. ProManus focuses its technological and business efforts on development and implementation of medical devices, which will significantly facilitate everyday’s life of many handicapped people globally, suffering from severe injuries. First products should reach the market within several months from the moment of establishing the startup company. More info at jciventure@jci.pl.
 
As a ProManus Ltd, the young and talented team of entrepreneurs, possessing patent applications in unique technological solutions, received financial and  technical support from team of JCI Venture. ProManus focuses its technological and business efforts on development and implementation of medical devices, which will significantly facilitate everyday’s life of many handicapped people globally, suffering from severe injuries. First products should reach the market within several months from the moment of establishing the startup company. More info at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .
 
JCI Venture Ltd. has established a new start-up company within it investment port folio. F1 Pharma Ltd. bonds years of experience of talented experts from R&D sector of internationally recognized pharmaceutical company, with capital investment of several hundreds of thousands zloty along with technical support derived from  JCI Venture resources. F1 Pharma focuses on  unique and perspective opportunities of pharmaceutical market, and its operational and business activity conducts at Life Science Technology Park and Bioinqubator, managed by the Jagiellonian Centre of Innovation Ltd.